185 related articles for article (PubMed ID: 34912000)
1. Changes in metabolic syndrome and risk of psoriasis: a nationwide population-based study.
Lee HJ; Han KD; Park HE; Han JH; Bang CH; Park YM; Lee JH
Sci Rep; 2021 Dec; 11(1):24043. PubMed ID: 34912000
[TBL] [Abstract][Full Text] [Related]
2. Metabolic syndrome is associated with an increased risk of psoriasis: A nationwide population-based study.
Kim HN; Han K; Park YG; Lee JH
Metabolism; 2019 Oct; 99():19-24. PubMed ID: 31279740
[TBL] [Abstract][Full Text] [Related]
3. Association between metabolic syndrome and incidence of ocular motor nerve palsy.
Choi DD; Han K; Oh SY; Park KA
Sci Rep; 2021 Nov; 11(1):23033. PubMed ID: 34845329
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome and risk of Parkinson disease: A nationwide cohort study.
Nam GE; Kim SM; Han K; Kim NH; Chung HS; Kim JW; Han B; Cho SJ; Yu JH; Park YG; Choi KM
PLoS Med; 2018 Aug; 15(8):e1002640. PubMed ID: 30130376
[TBL] [Abstract][Full Text] [Related]
5. Exposure-weighted scoring for metabolic syndrome and the risk of myocardial infarction and stroke: a nationwide population-based study.
Lee EY; Han K; Kim DH; Park YM; Kwon HS; Yoon KH; Kim MK; Lee SH
Cardiovasc Diabetol; 2020 Sep; 19(1):153. PubMed ID: 32993664
[TBL] [Abstract][Full Text] [Related]
6. Changes in metabolic syndrome status affect the incidence of end-stage renal disease in the general population: a nationwide cohort study.
Koh ES; Do Han K; Kim MK; Kim ES; Lee MK; Nam GE; Hong OK; Kwon HS
Sci Rep; 2021 Jan; 11(1):1957. PubMed ID: 33479302
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Metabolic Syndrome in Chinese Patients With Erythrodermic Psoriasis: A Case-Control Study.
Ma AR; Liu F; Wang R; Lin L; Wang Y; Li Q; Lu X; Du J
Front Endocrinol (Lausanne); 2021; 12():677912. PubMed ID: 34970217
[TBL] [Abstract][Full Text] [Related]
8. Association of metabolic syndrome and chronic kidney disease with atrial fibrillation: A nationwide population-based study in Korea.
Choe WS; Choi EK; Han KD; Lee EJ; Lee SR; Cha MJ; Oh S
Diabetes Res Clin Pract; 2019 Feb; 148():14-22. PubMed ID: 30578822
[TBL] [Abstract][Full Text] [Related]
9. The Effect of Tildrakizumab on Cardiometabolic Risk Factors in Psoriasis by Metabolic Syndrome Status: Post Hoc Analysis of Two Phase 3 Trials (ReSURFACE 1 and ReSURFACE 2).
Menter MA; Mehta NN; Lebwohl MG; Gottlieb AB; Mendelsohn AM; Rozzo SJ; Leonardi C
J Drugs Dermatol; 2020 Aug; 19(8):703-708. PubMed ID: 32845115
[TBL] [Abstract][Full Text] [Related]
10. Metabolic Syndrome and Parkinson's Disease Incidence: A Nationwide Study Using Propensity Score Matching.
Roh JH; Lee S; Yoon JH
Metab Syndr Relat Disord; 2021 Feb; 19(1):1-7. PubMed ID: 32876524
[No Abstract] [Full Text] [Related]
11. The relationship between metabolic syndrome and obstructive sleep apnea syndrome: a nationwide population-based study.
Kim DH; Kim B; Han K; Kim SW
Sci Rep; 2021 Apr; 11(1):8751. PubMed ID: 33888816
[TBL] [Abstract][Full Text] [Related]
12. Cumulative burden of metabolic syndrome and its components on the risk of atrial fibrillation: a nationwide population-based study.
Ahn HJ; Han KD; Choi EK; Jung JH; Kwon S; Lee SR; Oh S; Lip GYH
Cardiovasc Diabetol; 2021 Jan; 20(1):20. PubMed ID: 33468142
[TBL] [Abstract][Full Text] [Related]
13. Association between the severity of hard-to-treat psoriasis and the prevalence of metabolic syndrome: A hospital-based cross-sectional study in Jakarta, Indonesia.
Evyana D; Novianto E; Budianti WK; Krisanti RIA; Wisnu W; Wibawanti R; Nilasari H; Legiawati L; Hapsari SAR; Mutmainnah E
PLoS One; 2024; 19(4):e0302391. PubMed ID: 38683749
[TBL] [Abstract][Full Text] [Related]
14. Changes in Metabolic Syndrome Status are Associated With Altered Risk of Pancreatic Cancer: A Nationwide Cohort Study.
Park JH; Han K; Hong JY; Park YS; Hur KY; Kang G; Park JO
Gastroenterology; 2022 Feb; 162(2):509-520.e7. PubMed ID: 34653420
[TBL] [Abstract][Full Text] [Related]
15. Association Between Change in Metabolic Syndrome Status and Risk of Incident Atrial Fibrillation: A Nationwide Population-Based Study.
Lee SY; Lee SR; Choi EK; Kwon S; Yang S; Park J; Choi YJ; Lee HJ; Moon I; Lee E; Han KD; Cha MJ; Oh S; Lip GYH
J Am Heart Assoc; 2021 Aug; 10(16):e020901. PubMed ID: 34369167
[TBL] [Abstract][Full Text] [Related]
16. Proinflammatory Dietary Intake is Associated with Increased Risk of Metabolic Syndrome and Its Components: Results from the Population-Based Prospective Study.
Khan I; Kwon M; Shivappa N; R Hébert J; Kim MK
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32344617
[TBL] [Abstract][Full Text] [Related]
17. Impact of metabolic status on the incidence of psoriasis: a Korean nationwide cohort study.
Kim ES; Han K; Kim MK; Park YM; Baek KH; Moon SD; Han JH; Song KH; Kwon HS
Sci Rep; 2017 May; 7(1):1989. PubMed ID: 28512338
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of metabolic syndrome in patients with psoriasis: a cross-sectional study in Singapore.
Chan WMM; Yew YW; Theng TSC; Liew CF; Oon HH
Singapore Med J; 2020 Apr; 61(4):194-199. PubMed ID: 31788703
[TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome and risk of incident psoriasis: prospective data from the HUNT Study, Norway.
Snekvik I; Nilsen TIL; Romundstad PR; Saunes M
Br J Dermatol; 2019 Jan; 180(1):94-99. PubMed ID: 29904911
[TBL] [Abstract][Full Text] [Related]
20. Cumulative effect of metabolic syndrome on the risk of retinal vein occlusion in young patients: A nationwide population-based study.
Kim Y; Kim CG; Kim JW; Han K; Kim JH
PLoS One; 2024; 19(5):e0303871. PubMed ID: 38768233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
